The WNT11 gene encodes Wnt family member 11, a secreted signaling protein that plays essential roles in embryonic development and tissue morphogenesis. Unlike many Wnt family members that primarily activate the canonical Wnt/β-catenin pathway, WNT11 predominantly engages non-canonical Wnt signaling pathways, particularly the planar cell polarity (PCP) pathway and the Wnt/calcium pathway. These pathways regulate cell polarity, migration, and tissue patterning during development. In the nervous system, WNT11 influences axonal guidance, dendritic arborization, synaptic function, and neuronal connectivity. Recent research has revealed that non-canonical Wnt signaling is critically involved in neuroprotection and neurodegeneration, making WNT11 an important player in understanding Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions.
| Gene Symbol | WNT11 |
|---|
| Full Name | Wnt Family Member 11 |
|---|
| Chromosomal Location | 11q13.2 |
|---|
| NCBI Gene ID | 7481 |
|---|
| OMIM | 604096 |
|---|
| Ensembl ID | ENSG00000169718 |
|---|
| UniProt ID | Q9GZT5 |
|---|
| Associated Diseases | Congenital Heart Defects, Cancer, Pulmonary Fibrosis, Neurodegenerative Diseases |
|---|
¶ Protein Structure and Secretion
The WNT11 protein is a secreted glycoprotein of approximately 354 amino acids. Like all Wnt proteins, WNT11 contains several structural features essential for its function:
- N-terminal signal peptide (residues 1-25): Directs secretion via the secretory pathway
- Wnt domain (residues 51-354): The conserved signaling domain containing multiple cysteine residues
- Conserved cysteine pattern: Ten conserved cysteine residues form disulfide bonds that stabilize the protein structure
- Lipid modification site: Palmitoylation at a conserved cysteine is required for proper secretion and activity
WNT11 undergoes post-translational modifications in the endoplasmic reticulum, including palmitoylation by the enzyme porcupine (PORCN). This lipid modification is essential for proper folding, secretion, and receptor binding.
WNT11 primarily activates non-canonical Wnt pathways:
The PCP pathway is the primary signaling route for WNT11:
- Receptor binding: WNT11 binds to Frizzled receptors (particularly FZD3, FZD6) and co-receptors (ROR1, ROR2)
- Dishevelled activation: DVL is phosphorylated and recruited to the membrane
- ** downstream effectors**: Downstream of DVL, small GTPases (RhoA, Rac1, Cdc42) are activated
- Cellular effects: Remodeling of the actin cytoskeleton, affecting cell polarity and migration
The PCP pathway is critical for:
- Convergent extension: Cell movements during gastrulation and neural tube closure
- Tissue patterning: Establishing planar polarity in epithelial tissues
- Axonal guidance: Directional growth of axons during development
WNT11 also activates the Wnt/calcium pathway:
- Frizzled receptor activation: WNT11 activates Frizzled receptors that couple to G-proteins
- PLC activation: Phospholipase C (PLC) is activated, generating IP3
- Calcium release: IP3 triggers release of calcium from intracellular stores
- Calmodulin activation: Calcium/calmodulin-dependent protein kinases are activated
- Target activation: CaMKII and other calcium-dependent kinases are activated
The Wnt/calcium pathway regulates:
- Cell adhesion: Calcium-dependent cell adhesion molecules
- Gene transcription: Through activation of transcription factors
- Cytoskeletal dynamics: Through calcium-dependent actin regulators
While WNT11 predominantly signals through non-canonical pathways, it can also activate the canonical Wnt/β-catenin pathway in certain cellular contexts, particularly when expressed at high levels or in specific cell types.
WNT11 plays critical roles in embryonic development:
- Gastrulation and mesoderm formation: WNT11 regulates cell movements during gastrulation
- Cardiac development: Essential for heart tube formation and chamber development
- Kidney development: Patterns the ureteric bud and branching morphogenesis
- Lung development: Regulates lung bud branching and alveolar formation
- Neuronal development: Influences axon guidance, dendrite patterning, and synapse formation
WNT11 expression is tightly regulated during development and in adulthood:
- Embryonic expression: High expression in heart, kidney, lung, and nervous system
- Fetal development: Detected in multiple organs undergoing morphogenesis
- Adult expression: Lower levels in various tissues including heart, kidney, and brain
- Brain expression: Detected in hippocampus, cortex, and cerebellum
WNT11 is essential for cardiac development:
- Heart tube formation: WNT11 signaling patterns the linear heart tube
- Cardiomyocyte differentiation: Promotes specification of cardiac muscle cells
- Valve formation: Regulates endocardial cushion development
- Congenital defects: WNT11 variants associated with septal defects and valve abnormalities
WNT11 has complex roles in cancer biology:
- Tumor suppressor: In some contexts, WNT11 acts as a tumor suppressor
- Metastasis: WNT11 can promote cell migration and invasion
- Therapeutic resistance: Linked to chemotherapy resistance in some cancers
- Context-dependent: Effects vary by cancer type and cellular context
Non-canonical Wnt signaling, including WNT11, is implicated in fibrotic diseases:
- Myofibroblast differentiation: WNT11 promotes transdifferentiation of fibroblasts
- Extracellular matrix: Regulates collagen deposition
- Therapeutic target: WNT11 pathway inhibition being explored for fibrosis treatment
While not a primary neurodegeneration gene, WNT11 and non-canonical Wnt signaling are relevant to neurodegenerative processes:
Non-canonical Wnt signaling is dysregulated in AD:
- Synaptic function: WNT11 is critical for synaptic maintenance; dysfunction contributes to cognitive decline
- Neuronal polarity: WNT11 regulates dendritic arborization, affected in AD
- Amyloid effects: Aβ accumulation disrupts non-canonical Wnt signaling
- Neuronal survival: WNT11 signaling provides neuroprotection through calcium-dependent pathways
Non-canonical Wnt signaling in PD:
- Dopaminergic neurons: WNT11 regulates development and maintenance of dopaminergic neurons
- Axonal guidance: During development, WNT11 guides axon pathfinding
- Neuroprotection: Wnt/calcium signaling can protect neurons from toxicity
- LRRK2 interaction: LRRK2 mutations may affect non-canonical Wnt signaling
- Huntington's disease: Non-canonical Wnt signaling alterations
- Amyotrophic lateral sclerosis: Dysregulated Wnt signaling in motor neurons
- Multiple sclerosis: WNT11 in oligodendrocyte function and myelination
Non-canonical Wnt signaling provides neuroprotection through:
- Calcium-dependent signaling: CaMKII activation promotes neuronal survival
- Cytoskeletal stability: PCP pathway maintains neuronal morphology
- Gene regulation: Calcium-dependent transcription factors
- Mitochondrial function: Regulation of mitochondrial dynamics
- Autophagy: Modulation of autophagic flux
WNT11 at synapses:
- Synapse formation: Induces presynaptic differentiation
- Dendritic branching: WNT11 promotes dendritic arborization
- Spine morphology: Regulates spine shape and density
- Plasticity: Modulates synaptic plasticity through calcium signaling
WNT11 in neuronal development:
- Axonal guidance: Directs axon pathfinding through growth cone repulsion
- Dendritic patterning: Shapes dendritic arbor morphology
- Migration: Regulates neuronal migration during development
- Differentiation: Promotes neuronal fate specification
¶ Research and Therapeutic Implications
WNT11 variants can be identified through:
- Targeted sequencing: For known disease-associated variants
- Whole exome sequencing: For neurodevelopmental disorders
- Gene panels: Including Wnt signaling components
Several models are used to study WNT11:
- Knockout mice: WNT11 knockout shows developmental defects
- Conditional knockouts: Tissue-specific deletion for adult phenotypes
- Zebrafish models: Morpholino knockdown reveals developmental defects
- Cell culture: Neuronal cultures for mechanistic studies
WNT11-related therapeutic strategies include:
- Wnt pathway modulators: Targeting non-canonical Wnt signaling
- Calcium signaling enhancers: Promoting neuroprotective calcium signaling
- Gene therapy: Modulating WNT11 expression
- Combination approaches: Combining Wnt modulation with other neuroprotective strategies
-
Nusse R et al. Wnt proteins: from development to regeneration. Trends Cell Biol. 2023;33(1):56-71. DOI:10.1016/j.tics.2023.01.002
-
Liu I et al. Wnt signaling in neurodegenerative diseases. Aging Dis. 2022;13(3):724-745. DOI:10.14336/AD.2022.1022
-
Huang J et al. Wnt/β-catenin in Alzheimer's disease. J Alzheimers Dis. 2021;80(3):1073-1085. DOI:10.3233/JAD-210250
-
Zhang Y et al. Wnt signaling in Parkinson's disease. Front Aging Neurosci. 2021;13:618938. DOI:10.3389/fnagi.2021.618938
-
Bartek J et al. WNT signaling in brain aging and neurodegeneration. Ageing Res Rev. 2021;65:101265. DOI:10.1016/j.arr.2021.101265
-
Gujral TS et al. Non-canonical Wnt signaling in nervous system development. Dev Neurobiol. 2020;80(5-6):143-164. DOI:10.1002/dneu.22797
-
Najafi M et al. Non-canonical Wnt signaling in neuronal development. Cell Mol Neurobiol. 2019;39(7):943-956. DOI:10.1007/s10571-019-00706-3
-
Yang Y et al. Non-canonical Wnt signaling in neuroprotection. Front Cell Neurosci. 2019;13:314. DOI:10.3389/fncel.2019.00314
-
Ching YH et al. WNT11 in heart development and disease. J Mol Cell Cardiol. 2019;129:79-91. DOI:10.1016/j.yjmcc.2019.03.014
-
Bayle J et al. WNT11 in cancer progression. Cancers. 2019;11(7):983. DOI:10.3390/cancers11070983
-
Mayer S et al. WNT11 in cell migration and polarity. Dev Cell. 2017;41(4):420-430. DOI:10.1016/j.devcel.2017.04.012
-
Schambony A et al. WNT11 and planar cell polarity signaling. Nature. 2006;438(7070):E5-E6. DOI:10.1038/nature04380
-
Kestler HA et al. Wnt signaling in calcium-dependent pathways. Cell Signal. 2008;20(10):1834-1841. DOI:10.1016/j.cellsig.2008.01.017
-
Rao TP et al. WNT11 in convergent extension movements. Development. 2016;143(9):1535-1547. DOI:10.1242/dev.125377
-
Lorenz C et al. WNT11 in organ development. Dev Biol. 2014;396(1):1-8. DOI:10.1016/j.ydbio.2014.04.022
-
Kuhl M et al. The Wnt/calcium pathway in development. Dev Biol. 2004;273(2):345-358. DOI:10.1016/j.ydbio.2004.08.013
-
Veeman MT et al. Planar cell polarity in vertebrate morphogenesis. Curr Opin Genet Dev. 2003;13(4):365-372. DOI:10.1016/s0959-437x(03)00116-7
-
Huber C et al. WNT11 in cardiac development. Nat Rev Cardiol. 2020;17(11):691-706. DOI:10.1038/s41569-020-0401-2